nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—ALOX5—rheumatoid arthritis	0.227	0.53	CbGaD
Aminosalicylic Acid—CHUK—Sulfasalazine—rheumatoid arthritis	0.214	0.548	CbGbCtD
Aminosalicylic Acid—MPO—rheumatoid arthritis	0.146	0.342	CbGaD
Aminosalicylic Acid—ALOX5—Sulfasalazine—rheumatoid arthritis	0.0832	0.213	CbGbCtD
Aminosalicylic Acid—PTGS2—rheumatoid arthritis	0.0548	0.128	CbGaD
Aminosalicylic Acid—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0222	0.0568	CbGbCtD
Aminosalicylic Acid—PTGS2—Triamcinolone—rheumatoid arthritis	0.0222	0.0568	CbGbCtD
Aminosalicylic Acid—PTGS2—Betamethasone—rheumatoid arthritis	0.019	0.0487	CbGbCtD
Aminosalicylic Acid—PTGS1—Sulfasalazine—rheumatoid arthritis	0.0187	0.048	CbGbCtD
Aminosalicylic Acid—PTGS2—Dexamethasone—rheumatoid arthritis	0.0111	0.0283	CbGbCtD
Aminosalicylic Acid—MPO—saliva—rheumatoid arthritis	0.00227	0.18	CbGeAlD
Aminosalicylic Acid—PTGS2—skeletal joint—rheumatoid arthritis	0.00143	0.113	CbGeAlD
Aminosalicylic Acid—CHUK—connective tissue—rheumatoid arthritis	0.00111	0.0875	CbGeAlD
Aminosalicylic Acid—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	0.00109	0.0859	CbGeAlD
Aminosalicylic Acid—PTGS2—cartilage tissue—rheumatoid arthritis	0.00096	0.076	CbGeAlD
Aminosalicylic Acid—CHUK—lymphoid tissue—rheumatoid arthritis	0.000808	0.064	CbGeAlD
Aminosalicylic Acid—CHUK—digestive system—rheumatoid arthritis	0.000798	0.0632	CbGeAlD
Aminosalicylic Acid—Mesalazine—ALOX5—rheumatoid arthritis	0.000649	0.358	CrCbGaD
Aminosalicylic Acid—ALOX5—connective tissue—rheumatoid arthritis	0.000623	0.0493	CbGeAlD
Aminosalicylic Acid—MPO—connective tissue—rheumatoid arthritis	0.000527	0.0417	CbGeAlD
Aminosalicylic Acid—ALOX5—lymphoid tissue—rheumatoid arthritis	0.000455	0.036	CbGeAlD
Aminosalicylic Acid—ALOX5—digestive system—rheumatoid arthritis	0.00045	0.0356	CbGeAlD
Aminosalicylic Acid—Mesalazine—MPO—rheumatoid arthritis	0.000418	0.231	CrCbGaD
Aminosalicylic Acid—MPO—lymphoid tissue—rheumatoid arthritis	0.000385	0.0305	CbGeAlD
Aminosalicylic Acid—MPO—digestive system—rheumatoid arthritis	0.000381	0.0301	CbGeAlD
Aminosalicylic Acid—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000301	0.159	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.000296	0.156	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.000296	0.156	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000289	0.153	CbGdCrCtD
Aminosalicylic Acid—Vasculitis—Dexamethasone—rheumatoid arthritis	0.00026	0.00381	CcSEcCtD
Aminosalicylic Acid—Purpura—Cyclosporine—rheumatoid arthritis	0.000252	0.00369	CcSEcCtD
Aminosalicylic Acid—Urticaria—Penicillamine—rheumatoid arthritis	0.00025	0.00366	CcSEcCtD
Aminosalicylic Acid—PTGS1—connective tissue—rheumatoid arthritis	0.00025	0.0198	CbGeAlD
Aminosalicylic Acid—Hypoglycaemia—Cyclosporine—rheumatoid arthritis	0.000249	0.00364	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Penicillamine—rheumatoid arthritis	0.000249	0.00364	CcSEcCtD
Aminosalicylic Acid—Nausea—Ergocalciferol—rheumatoid arthritis	0.000248	0.00363	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Leflunomide—rheumatoid arthritis	0.000246	0.0036	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Azathioprine—rheumatoid arthritis	0.00024	0.00351	CcSEcCtD
Aminosalicylic Acid—PTGS2—connective tissue—rheumatoid arthritis	0.000239	0.0189	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Leflunomide—rheumatoid arthritis	0.000238	0.00348	CcSEcCtD
Aminosalicylic Acid—Jaundice—Leflunomide—rheumatoid arthritis	0.000236	0.00346	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Auranofin—rheumatoid arthritis	0.000233	0.00341	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.000232	0.00339	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Triamcinolone—rheumatoid arthritis	0.000227	0.00333	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Prednisone—rheumatoid arthritis	0.000227	0.00332	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Leflunomide—rheumatoid arthritis	0.000226	0.00331	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Leflunomide—rheumatoid arthritis	0.000218	0.00319	CcSEcCtD
Aminosalicylic Acid—Vomiting—Auranofin—rheumatoid arthritis	0.000217	0.00317	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Penicillamine—rheumatoid arthritis	0.000215	0.00315	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Leflunomide—rheumatoid arthritis	0.000215	0.00315	CcSEcCtD
Aminosalicylic Acid—Rash—Auranofin—rheumatoid arthritis	0.000215	0.00314	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Auranofin—rheumatoid arthritis	0.000215	0.00314	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Leflunomide—rheumatoid arthritis	0.000213	0.00312	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Cyclosporine—rheumatoid arthritis	0.000211	0.00309	CcSEcCtD
Aminosalicylic Acid—Purpura—Triamcinolone—rheumatoid arthritis	0.000211	0.00309	CcSEcCtD
Aminosalicylic Acid—Nausea—Auranofin—rheumatoid arthritis	0.000202	0.00296	CcSEcCtD
Aminosalicylic Acid—Vomiting—Penicillamine—rheumatoid arthritis	0.0002	0.00293	CcSEcCtD
Aminosalicylic Acid—Diflunisal—PTGS2—rheumatoid arthritis	0.0002	0.11	CrCbGaD
Aminosalicylic Acid—Rash—Penicillamine—rheumatoid arthritis	0.000198	0.0029	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Penicillamine—rheumatoid arthritis	0.000198	0.0029	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisolone—rheumatoid arthritis	0.000192	0.00281	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Cyclosporine—rheumatoid arthritis	0.00019	0.00278	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Leflunomide—rheumatoid arthritis	0.00019	0.00277	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Methotrexate—rheumatoid arthritis	0.00019	0.00277	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Hydrocortisone—rheumatoid arthritis	0.000188	0.00275	CcSEcCtD
Aminosalicylic Acid—Nausea—Penicillamine—rheumatoid arthritis	0.000187	0.00274	CcSEcCtD
Aminosalicylic Acid—Flatulence—Leflunomide—rheumatoid arthritis	0.000187	0.00273	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Leflunomide—rheumatoid arthritis	0.000186	0.00272	CcSEcCtD
Aminosalicylic Acid—Anaemia—Azathioprine—rheumatoid arthritis	0.000186	0.00271	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Cyclosporine—rheumatoid arthritis	0.000184	0.00269	CcSEcCtD
Aminosalicylic Acid—Jaundice—Cyclosporine—rheumatoid arthritis	0.000183	0.00267	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000181	0.0958	CbGdCrCtD
Aminosalicylic Acid—PTGS1—digestive system—rheumatoid arthritis	0.000181	0.0143	CbGeAlD
Aminosalicylic Acid—Leukopenia—Azathioprine—rheumatoid arthritis	0.00018	0.00263	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Prednisone—rheumatoid arthritis	0.00018	0.00263	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000179	0.0942	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000179	0.0942	CbGdCrCtD
Aminosalicylic Acid—Diflunisal—ALB—rheumatoid arthritis	0.000178	0.0982	CrCbGaD
Aminosalicylic Acid—Abdominal distension—Triamcinolone—rheumatoid arthritis	0.000177	0.00259	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Methylprednisolone—rheumatoid arthritis	0.000177	0.00258	CcSEcCtD
Aminosalicylic Acid—Anaemia—Leflunomide—rheumatoid arthritis	0.000175	0.00256	CcSEcCtD
Aminosalicylic Acid—PTGS2—lymphoid tissue—rheumatoid arthritis	0.000175	0.0138	CbGeAlD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000174	0.0921	CbGdCrCtD
Aminosalicylic Acid—PTGS2—digestive system—rheumatoid arthritis	0.000173	0.0137	CbGeAlD
Aminosalicylic Acid—PTGS1—tendon—rheumatoid arthritis	0.000172	0.0136	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.00017	0.00248	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Leflunomide—rheumatoid arthritis	0.00017	0.00248	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Hydrocortisone—rheumatoid arthritis	0.000169	0.00247	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Cyclosporine—rheumatoid arthritis	0.000168	0.00246	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisolone—rheumatoid arthritis	0.000167	0.00244	CcSEcCtD
Aminosalicylic Acid—Purpura—Prednisone—rheumatoid arthritis	0.000167	0.00244	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Cyclosporine—rheumatoid arthritis	0.000166	0.00243	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Cyclosporine—rheumatoid arthritis	0.000165	0.00241	CcSEcCtD
Aminosalicylic Acid—PTGS2—tendon—rheumatoid arthritis	0.000164	0.013	CbGeAlD
Aminosalicylic Acid—Neuropathy peripheral—Hydrocortisone—rheumatoid arthritis	0.000163	0.00239	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Prednisone—rheumatoid arthritis	0.000161	0.00235	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Azathioprine—rheumatoid arthritis	0.00016	0.00235	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.00016	0.00235	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Azathioprine—rheumatoid arthritis	0.000159	0.00233	CcSEcCtD
Aminosalicylic Acid—Mesalazine—PTGS2—rheumatoid arthritis	0.000157	0.0865	CrCbGaD
Aminosalicylic Acid—Neuropathy peripheral—Triamcinolone—rheumatoid arthritis	0.000154	0.00225	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Methylprednisolone—rheumatoid arthritis	0.000153	0.00224	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.000152	0.00222	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Leflunomide—rheumatoid arthritis	0.000151	0.00222	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Leflunomide—rheumatoid arthritis	0.00015	0.0022	CcSEcCtD
Aminosalicylic Acid—Anorexia—Leflunomide—rheumatoid arthritis	0.000147	0.00216	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Cyclosporine—rheumatoid arthritis	0.000146	0.00214	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Dexamethasone—rheumatoid arthritis	0.000144	0.00211	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Betamethasone—rheumatoid arthritis	0.000144	0.00211	CcSEcCtD
Aminosalicylic Acid—Flatulence—Cyclosporine—rheumatoid arthritis	0.000144	0.00211	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Cyclosporine—rheumatoid arthritis	0.000143	0.0021	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—rheumatoid arthritis	0.000142	0.00208	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000141	0.00207	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisone—rheumatoid arthritis	0.00014	0.00205	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Dexamethasone—rheumatoid arthritis	0.000139	0.00204	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Betamethasone—rheumatoid arthritis	0.000139	0.00204	CcSEcCtD
Aminosalicylic Acid—Anaemia—Cyclosporine—rheumatoid arthritis	0.000135	0.00198	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Leflunomide—rheumatoid arthritis	0.000135	0.00197	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Azathioprine—rheumatoid arthritis	0.000134	0.00196	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.000134	0.00195	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Cyclosporine—rheumatoid arthritis	0.000131	0.00192	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Hydrocortisone—rheumatoid arthritis	0.00013	0.0019	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Azathioprine—rheumatoid arthritis	0.00013	0.0019	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Azathioprine—rheumatoid arthritis	0.00013	0.0019	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Leflunomide—rheumatoid arthritis	0.000127	0.00185	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Prednisone—rheumatoid arthritis	0.000126	0.00184	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000124	0.00181	CcSEcCtD
Aminosalicylic Acid—Urticaria—Leflunomide—rheumatoid arthritis	0.000123	0.0018	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Leflunomide—rheumatoid arthritis	0.000122	0.00179	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Leflunomide—rheumatoid arthritis	0.000122	0.00179	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.000122	0.00179	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisone—rheumatoid arthritis	0.000121	0.00178	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.000121	0.00177	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Triamcinolone—rheumatoid arthritis	0.00012	0.00175	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000117	0.00171	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	0.000117	0.00171	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000116	0.0017	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.000114	0.00167	CcSEcCtD
Aminosalicylic Acid—Anorexia—Cyclosporine—rheumatoid arthritis	0.000114	0.00167	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Azathioprine—rheumatoid arthritis	0.000112	0.00164	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—rheumatoid arthritis	0.000111	0.0613	CrCbGaD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.00011	0.00161	CcSEcCtD
Aminosalicylic Acid—Dizziness—Azathioprine—rheumatoid arthritis	0.000108	0.00159	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Leflunomide—rheumatoid arthritis	0.000106	0.00155	CcSEcCtD
Aminosalicylic Acid—Vomiting—Azathioprine—rheumatoid arthritis	0.000104	0.00152	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000104	0.00152	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Cyclosporine—rheumatoid arthritis	0.000104	0.00152	CcSEcCtD
Aminosalicylic Acid—Rash—Azathioprine—rheumatoid arthritis	0.000103	0.00151	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000103	0.00151	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Azathioprine—rheumatoid arthritis	0.000103	0.00151	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.000103	0.00151	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000103	0.00151	CcSEcCtD
Aminosalicylic Acid—Headache—Azathioprine—rheumatoid arthritis	0.000103	0.0015	CcSEcCtD
Aminosalicylic Acid—Dizziness—Leflunomide—rheumatoid arthritis	0.000102	0.0015	CcSEcCtD
Aminosalicylic Acid—Anorexia—Hydrocortisone—rheumatoid arthritis	0.000101	0.00148	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—rheumatoid arthritis	9.9e-05	0.0546	CrCbGaD
Aminosalicylic Acid—Vomiting—Leflunomide—rheumatoid arthritis	9.84e-05	0.00144	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	9.78e-05	0.00143	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	9.76e-05	0.00143	CcSEcCtD
Aminosalicylic Acid—Rash—Leflunomide—rheumatoid arthritis	9.76e-05	0.00143	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Leflunomide—rheumatoid arthritis	9.75e-05	0.00143	CcSEcCtD
Aminosalicylic Acid—Nausea—Azathioprine—rheumatoid arthritis	9.73e-05	0.00142	CcSEcCtD
Aminosalicylic Acid—Headache—Leflunomide—rheumatoid arthritis	9.69e-05	0.00142	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methylprednisolone—rheumatoid arthritis	9.68e-05	0.00142	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Prednisone—rheumatoid arthritis	9.68e-05	0.00142	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—rheumatoid arthritis	9.66e-05	0.00141	CcSEcCtD
Aminosalicylic Acid—Urticaria—Cyclosporine—rheumatoid arthritis	9.49e-05	0.00139	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Cyclosporine—rheumatoid arthritis	9.44e-05	0.00138	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Cyclosporine—rheumatoid arthritis	9.44e-05	0.00138	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Methotrexate—rheumatoid arthritis	9.29e-05	0.00136	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Hydrocortisone—rheumatoid arthritis	9.23e-05	0.00135	CcSEcCtD
Aminosalicylic Acid—Nausea—Leflunomide—rheumatoid arthritis	9.19e-05	0.00134	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—rheumatoid arthritis	9.17e-05	0.00134	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	9.16e-05	0.00134	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—rheumatoid arthritis	9.11e-05	0.00133	CcSEcCtD
Aminosalicylic Acid—Anaemia—Prednisone—rheumatoid arthritis	8.94e-05	0.00131	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Betamethasone—rheumatoid arthritis	8.89e-05	0.0013	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Dexamethasone—rheumatoid arthritis	8.89e-05	0.0013	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Betamethasone—rheumatoid arthritis	8.88e-05	0.0013	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	8.88e-05	0.0013	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Cyclosporine—rheumatoid arthritis	8.8e-05	0.00129	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	8.68e-05	0.00127	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dexamethasone—rheumatoid arthritis	8.64e-05	0.00126	CcSEcCtD
Aminosalicylic Acid—Anorexia—Betamethasone—rheumatoid arthritis	8.64e-05	0.00126	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisolone—rheumatoid arthritis	8.63e-05	0.00126	CcSEcCtD
Aminosalicylic Acid—Urticaria—Hydrocortisone—rheumatoid arthritis	8.43e-05	0.00123	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Hydrocortisone—rheumatoid arthritis	8.39e-05	0.00123	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Hydrocortisone—rheumatoid arthritis	8.39e-05	0.00123	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	8.18e-05	0.0012	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Cyclosporine—rheumatoid arthritis	8.17e-05	0.0012	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	8.15e-05	0.00119	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—rheumatoid arthritis	8.09e-05	0.00118	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisolone—rheumatoid arthritis	8.01e-05	0.00117	CcSEcCtD
Aminosalicylic Acid—Urticaria—Triamcinolone—rheumatoid arthritis	7.94e-05	0.00116	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methylprednisolone—rheumatoid arthritis	7.92e-05	0.00116	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—rheumatoid arthritis	7.92e-05	0.00116	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Triamcinolone—rheumatoid arthritis	7.9e-05	0.00116	CcSEcCtD
Aminosalicylic Acid—Dizziness—Cyclosporine—rheumatoid arthritis	7.9e-05	0.00116	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methylprednisolone—rheumatoid arthritis	7.88e-05	0.00115	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dexamethasone—rheumatoid arthritis	7.88e-05	0.00115	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Betamethasone—rheumatoid arthritis	7.88e-05	0.00115	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	7.83e-05	0.00115	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	7.83e-05	0.00115	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	7.82e-05	0.00114	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Prednisone—rheumatoid arthritis	7.74e-05	0.00113	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Prednisone—rheumatoid arthritis	7.67e-05	0.00112	CcSEcCtD
Aminosalicylic Acid—Vomiting—Cyclosporine—rheumatoid arthritis	7.59e-05	0.00111	CcSEcCtD
Aminosalicylic Acid—Rash—Cyclosporine—rheumatoid arthritis	7.53e-05	0.0011	CcSEcCtD
Aminosalicylic Acid—Anorexia—Prednisone—rheumatoid arthritis	7.53e-05	0.0011	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Cyclosporine—rheumatoid arthritis	7.52e-05	0.0011	CcSEcCtD
Aminosalicylic Acid—Headache—Cyclosporine—rheumatoid arthritis	7.48e-05	0.00109	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—rheumatoid arthritis	7.47e-05	0.00109	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	7.41e-05	0.00108	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	7.41e-05	0.00108	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Triamcinolone—rheumatoid arthritis	7.36e-05	0.00108	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	7.35e-05	0.00107	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Hydrocortisone—rheumatoid arthritis	7.26e-05	0.00106	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—rheumatoid arthritis	7.24e-05	0.00106	CcSEcCtD
Aminosalicylic Acid—Urticaria—Dexamethasone—rheumatoid arthritis	7.2e-05	0.00105	CcSEcCtD
Aminosalicylic Acid—Urticaria—Betamethasone—rheumatoid arthritis	7.2e-05	0.00105	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisolone—rheumatoid arthritis	7.19e-05	0.00105	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Betamethasone—rheumatoid arthritis	7.17e-05	0.00105	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dexamethasone—rheumatoid arthritis	7.17e-05	0.00105	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Betamethasone—rheumatoid arthritis	7.17e-05	0.00105	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dexamethasone—rheumatoid arthritis	7.17e-05	0.00105	CcSEcCtD
Aminosalicylic Acid—Nausea—Cyclosporine—rheumatoid arthritis	7.09e-05	0.00104	CcSEcCtD
Aminosalicylic Acid—Dizziness—Hydrocortisone—rheumatoid arthritis	7.02e-05	0.00103	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Prednisone—rheumatoid arthritis	6.86e-05	0.001	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisolone—rheumatoid arthritis	6.85e-05	0.001	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisolone—rheumatoid arthritis	6.85e-05	0.001	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	6.84e-05	0.001	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methylprednisolone—rheumatoid arthritis	6.82e-05	0.000998	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisolone—rheumatoid arthritis	6.81e-05	0.000996	CcSEcCtD
Aminosalicylic Acid—Vomiting—Hydrocortisone—rheumatoid arthritis	6.75e-05	0.000987	CcSEcCtD
Aminosalicylic Acid—Rash—Hydrocortisone—rheumatoid arthritis	6.69e-05	0.000979	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Hydrocortisone—rheumatoid arthritis	6.69e-05	0.000978	CcSEcCtD
Aminosalicylic Acid—Headache—Hydrocortisone—rheumatoid arthritis	6.65e-05	0.000973	CcSEcCtD
Aminosalicylic Acid—Dizziness—Triamcinolone—rheumatoid arthritis	6.61e-05	0.000967	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methylprednisolone—rheumatoid arthritis	6.59e-05	0.000965	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—rheumatoid arthritis	6.47e-05	0.000947	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—rheumatoid arthritis	6.46e-05	0.000945	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Prednisone—rheumatoid arthritis	6.46e-05	0.000945	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisolone—rheumatoid arthritis	6.45e-05	0.000944	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—rheumatoid arthritis	6.41e-05	0.000938	CcSEcCtD
Aminosalicylic Acid—Vomiting—Triamcinolone—rheumatoid arthritis	6.35e-05	0.00093	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methylprednisolone—rheumatoid arthritis	6.34e-05	0.000928	CcSEcCtD
Aminosalicylic Acid—Nausea—Hydrocortisone—rheumatoid arthritis	6.3e-05	0.000922	CcSEcCtD
Aminosalicylic Acid—Rash—Triamcinolone—rheumatoid arthritis	6.3e-05	0.000922	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Triamcinolone—rheumatoid arthritis	6.29e-05	0.000921	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—rheumatoid arthritis	6.29e-05	0.00092	CcSEcCtD
Aminosalicylic Acid—Rash—Methylprednisolone—rheumatoid arthritis	6.29e-05	0.00092	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methylprednisolone—rheumatoid arthritis	6.28e-05	0.000919	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisone—rheumatoid arthritis	6.27e-05	0.000918	CcSEcCtD
Aminosalicylic Acid—Headache—Triamcinolone—rheumatoid arthritis	6.26e-05	0.000916	CcSEcCtD
Aminosalicylic Acid—Headache—Methylprednisolone—rheumatoid arthritis	6.25e-05	0.000914	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Prednisone—rheumatoid arthritis	6.24e-05	0.000913	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Prednisone—rheumatoid arthritis	6.24e-05	0.000913	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dexamethasone—rheumatoid arthritis	6.2e-05	0.000908	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Betamethasone—rheumatoid arthritis	6.2e-05	0.000908	CcSEcCtD
Aminosalicylic Acid—Dizziness—Dexamethasone—rheumatoid arthritis	6e-05	0.000877	CcSEcCtD
Aminosalicylic Acid—Dizziness—Betamethasone—rheumatoid arthritis	6e-05	0.000877	CcSEcCtD
Aminosalicylic Acid—Nausea—Triamcinolone—rheumatoid arthritis	5.94e-05	0.000868	CcSEcCtD
Aminosalicylic Acid—Nausea—Methylprednisolone—rheumatoid arthritis	5.92e-05	0.000867	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisone—rheumatoid arthritis	5.82e-05	0.000851	CcSEcCtD
Aminosalicylic Acid—Vomiting—Betamethasone—rheumatoid arthritis	5.77e-05	0.000843	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dexamethasone—rheumatoid arthritis	5.77e-05	0.000843	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—rheumatoid arthritis	5.74e-05	0.000839	CcSEcCtD
Aminosalicylic Acid—Rash—Dexamethasone—rheumatoid arthritis	5.72e-05	0.000836	CcSEcCtD
Aminosalicylic Acid—Rash—Betamethasone—rheumatoid arthritis	5.72e-05	0.000836	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Dexamethasone—rheumatoid arthritis	5.71e-05	0.000836	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Betamethasone—rheumatoid arthritis	5.71e-05	0.000836	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	5.7e-05	0.000834	CcSEcCtD
Aminosalicylic Acid—Headache—Betamethasone—rheumatoid arthritis	5.68e-05	0.000831	CcSEcCtD
Aminosalicylic Acid—Headache—Dexamethasone—rheumatoid arthritis	5.68e-05	0.000831	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Prednisone—rheumatoid arthritis	5.4e-05	0.00079	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	5.4e-05	0.00079	CcSEcCtD
Aminosalicylic Acid—Nausea—Dexamethasone—rheumatoid arthritis	5.39e-05	0.000788	CcSEcCtD
Aminosalicylic Acid—Nausea—Betamethasone—rheumatoid arthritis	5.39e-05	0.000788	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—rheumatoid arthritis	5.24e-05	0.000767	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisone—rheumatoid arthritis	5.22e-05	0.000764	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—rheumatoid arthritis	5.22e-05	0.000763	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—rheumatoid arthritis	5.22e-05	0.000763	CcSEcCtD
Aminosalicylic Acid—Vomiting—Prednisone—rheumatoid arthritis	5.02e-05	0.000735	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisone—rheumatoid arthritis	4.98e-05	0.000728	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisone—rheumatoid arthritis	4.97e-05	0.000728	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisone—rheumatoid arthritis	4.95e-05	0.000724	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—rheumatoid arthritis	4.86e-05	0.000711	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisone—rheumatoid arthritis	4.69e-05	0.000686	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—rheumatoid arthritis	4.52e-05	0.000661	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—rheumatoid arthritis	4.36e-05	0.000638	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—rheumatoid arthritis	4.2e-05	0.000614	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—rheumatoid arthritis	4.16e-05	0.000609	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—rheumatoid arthritis	4.16e-05	0.000608	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—rheumatoid arthritis	4.13e-05	0.000605	CcSEcCtD
Aminosalicylic Acid—Nausea—Methotrexate—rheumatoid arthritis	3.92e-05	0.000574	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—rheumatoid arthritis	1.32e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FCGR2A—rheumatoid arthritis	1.31e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC25A12—rheumatoid arthritis	1.31e-05	0.000135	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TRAF6—rheumatoid arthritis	1.31e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL1B—rheumatoid arthritis	1.3e-05	0.000134	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—rheumatoid arthritis	1.3e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RBPJ—rheumatoid arthritis	1.29e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TNFAIP3—rheumatoid arthritis	1.29e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.29e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BLK—rheumatoid arthritis	1.27e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-B—rheumatoid arthritis	1.27e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—rheumatoid arthritis	1.26e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTPN2—rheumatoid arthritis	1.26e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PLB1—rheumatoid arthritis	1.25e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—rheumatoid arthritis	1.24e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NCF2—rheumatoid arthritis	1.24e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SAA1—rheumatoid arthritis	1.23e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—C3—rheumatoid arthritis	1.23e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NFKB1—rheumatoid arthritis	1.22e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLD4—rheumatoid arthritis	1.21e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NCF1—rheumatoid arthritis	1.21e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTSD—rheumatoid arthritis	1.21e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	1.2e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NFKB1—rheumatoid arthritis	1.2e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—rheumatoid arthritis	1.19e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PLB1—rheumatoid arthritis	1.19e-05	0.000122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—C3—rheumatoid arthritis	1.18e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—rheumatoid arthritis	1.18e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-A—rheumatoid arthritis	1.18e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—rheumatoid arthritis	1.18e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MAPK8—rheumatoid arthritis	1.18e-05	0.000121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CRP—rheumatoid arthritis	1.17e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—rheumatoid arthritis	1.17e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ACAN—rheumatoid arthritis	1.17e-05	0.00012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD28—rheumatoid arthritis	1.16e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CAT—rheumatoid arthritis	1.14e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL13—rheumatoid arthritis	1.14e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	1.14e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTPRC—rheumatoid arthritis	1.14e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SAA1—rheumatoid arthritis	1.14e-05	0.000117	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1RN—rheumatoid arthritis	1.13e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.13e-05	0.000116	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR4—rheumatoid arthritis	1.12e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	1.12e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NCF1—rheumatoid arthritis	1.11e-05	0.000114	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ENO1—rheumatoid arthritis	1.1e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—rheumatoid arthritis	1.1e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—rheumatoid arthritis	1.1e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—rheumatoid arthritis	1.1e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DPB1—rheumatoid arthritis	1.1e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	1.1e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MED1—rheumatoid arthritis	1.1e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—RBPJ—rheumatoid arthritis	1.1e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—UBE2D1—rheumatoid arthritis	1.09e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—rheumatoid arthritis	1.09e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—rheumatoid arthritis	1.08e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRB1—rheumatoid arthritis	1.08e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—rheumatoid arthritis	1.08e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6ST—rheumatoid arthritis	1.08e-05	0.000111	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD28—rheumatoid arthritis	1.07e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GC—rheumatoid arthritis	1.07e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTGES—rheumatoid arthritis	1.07e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40—rheumatoid arthritis	1.06e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ADRBK1—rheumatoid arthritis	1.06e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HMGB1—rheumatoid arthritis	1.04e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTLA4—rheumatoid arthritis	1.04e-05	0.000107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD80—rheumatoid arthritis	1.04e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ICAM1—rheumatoid arthritis	1.03e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IRAK1—rheumatoid arthritis	1.03e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TLE3—rheumatoid arthritis	1.03e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—B3GNT2—rheumatoid arthritis	1.02e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ACP5—rheumatoid arthritis	1.02e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CX3CR1—rheumatoid arthritis	1.02e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—UBE2D1—rheumatoid arthritis	1.01e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RASGRP1—rheumatoid arthritis	9.99e-06	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SYK—rheumatoid arthritis	9.96e-06	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD79A—rheumatoid arthritis	9.96e-06	0.000102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD80—rheumatoid arthritis	9.96e-06	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PLB1—rheumatoid arthritis	9.94e-06	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	9.87e-06	0.000101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2RB—rheumatoid arthritis	9.81e-06	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	9.79e-06	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—ADRBK1—rheumatoid arthritis	9.78e-06	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRKCQ—rheumatoid arthritis	9.78e-06	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—rheumatoid arthritis	9.76e-06	0.0001	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ACP5—rheumatoid arthritis	9.67e-06	9.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—B3GNT2—rheumatoid arthritis	9.67e-06	9.92e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	9.62e-06	9.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6R—rheumatoid arthritis	9.61e-06	9.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT1—rheumatoid arthritis	9.61e-06	9.85e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—rheumatoid arthritis	9.55e-06	9.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—C5—rheumatoid arthritis	9.48e-06	9.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFATC1—rheumatoid arthritis	9.32e-06	9.56e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—VCAM1—rheumatoid arthritis	9.22e-06	9.45e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DQA1—rheumatoid arthritis	9.19e-06	9.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—BGN—rheumatoid arthritis	9.19e-06	9.42e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	9.03e-06	9.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PRKCQ—rheumatoid arthritis	9.03e-06	9.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR6—rheumatoid arthritis	8.91e-06	9.14e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	8.88e-06	9.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT1—rheumatoid arthritis	8.87e-06	9.1e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TYK2—rheumatoid arthritis	8.76e-06	8.98e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MED1—rheumatoid arthritis	8.71e-06	8.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TLE3—rheumatoid arthritis	8.71e-06	8.93e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—BGN—rheumatoid arthritis	8.71e-06	8.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCF2—rheumatoid arthritis	8.67e-06	8.89e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DQB1—rheumatoid arthritis	8.6e-06	8.82e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALOX5—rheumatoid arthritis	8.46e-06	8.67e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SH2B3—rheumatoid arthritis	8.45e-06	8.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TRAF6—rheumatoid arthritis	8.45e-06	8.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—GZMB—rheumatoid arthritis	8.39e-06	8.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTK2—rheumatoid arthritis	8.31e-06	8.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1A—rheumatoid arthritis	8.17e-06	8.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	8.15e-06	8.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL18—rheumatoid arthritis	8.15e-06	8.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL3—rheumatoid arthritis	8.15e-06	8.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL2—rheumatoid arthritis	8.15e-06	8.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—rheumatoid arthritis	8.12e-06	8.33e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	8.1e-06	8.31e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ACP5—rheumatoid arthritis	8.1e-06	8.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—rheumatoid arthritis	8.03e-06	8.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CSF2—rheumatoid arthritis	8.03e-06	8.24e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SAA1—rheumatoid arthritis	7.97e-06	8.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SLC11A1—rheumatoid arthritis	7.95e-06	8.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—rheumatoid arthritis	7.92e-06	8.12e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NFATC1—rheumatoid arthritis	7.89e-06	8.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—AGER—rheumatoid arthritis	7.83e-06	8.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCF1—rheumatoid arthritis	7.8e-06	8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-B—rheumatoid arthritis	7.72e-06	7.92e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—POMC—rheumatoid arthritis	7.64e-06	7.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—rheumatoid arthritis	7.64e-06	7.83e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	7.61e-06	7.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—rheumatoid arthritis	7.6e-06	7.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—rheumatoid arthritis	7.51e-06	7.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD28—rheumatoid arthritis	7.5e-06	7.7e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	7.44e-06	7.63e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NCF2—rheumatoid arthritis	7.33e-06	7.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—BGN—rheumatoid arthritis	7.29e-06	7.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2RA—rheumatoid arthritis	7.24e-06	7.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—C3—rheumatoid arthritis	7.18e-06	7.36e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-A—rheumatoid arthritis	7.16e-06	7.34e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—UBE2D1—rheumatoid arthritis	7.06e-06	7.25e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—rheumatoid arthritis	6.96e-06	7.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.93e-06	7.11e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL12—rheumatoid arthritis	6.93e-06	7.11e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ENO1—rheumatoid arthritis	6.89e-06	7.07e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.85e-06	7.03e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—rheumatoid arthritis	6.83e-06	7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NFKB1—rheumatoid arthritis	6.82e-06	7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCR5—rheumatoid arthritis	6.78e-06	6.96e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	6.78e-06	6.95e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SAA1—rheumatoid arthritis	6.74e-06	6.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	6.71e-06	6.88e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	6.71e-06	6.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MAPK8—rheumatoid arthritis	6.71e-06	6.88e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—rheumatoid arthritis	6.66e-06	6.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—rheumatoid arthritis	6.63e-06	6.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HLA-A—rheumatoid arthritis	6.61e-06	6.78e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NCF1—rheumatoid arthritis	6.6e-06	6.77e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NFKB1—rheumatoid arthritis	6.55e-06	6.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—rheumatoid arthritis	6.55e-06	6.71e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—rheumatoid arthritis	6.54e-06	6.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ENO1—rheumatoid arthritis	6.53e-06	6.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.46e-06	6.63e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SYK—rheumatoid arthritis	6.44e-06	6.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD28—rheumatoid arthritis	6.35e-06	6.51e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.32e-06	6.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ICAM1—rheumatoid arthritis	6.28e-06	6.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6ST—rheumatoid arthritis	6.28e-06	6.44e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT1—rheumatoid arthritis	6.21e-06	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL10—rheumatoid arthritis	6.12e-06	6.28e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—rheumatoid arthritis	6.09e-06	6.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD80—rheumatoid arthritis	6.04e-06	6.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—UBE2D1—rheumatoid arthritis	5.98e-06	6.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.93e-06	6.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	5.9e-06	6.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—ADRBK1—rheumatoid arthritis	5.79e-06	5.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6ST—rheumatoid arthritis	5.79e-06	5.94e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—rheumatoid arthritis	5.75e-06	5.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6R—rheumatoid arthritis	5.6e-06	5.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP3—rheumatoid arthritis	5.58e-06	5.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD80—rheumatoid arthritis	5.58e-06	5.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ENO1—rheumatoid arthritis	5.47e-06	5.61e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.38e-06	5.52e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTK2—rheumatoid arthritis	5.38e-06	5.51e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRKCQ—rheumatoid arthritis	5.35e-06	5.49e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL5—rheumatoid arthritis	5.27e-06	5.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT1—rheumatoid arthritis	5.25e-06	5.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CSF2—rheumatoid arthritis	5.19e-06	5.33e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6R—rheumatoid arthritis	5.17e-06	5.3e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TYK2—rheumatoid arthritis	5.1e-06	5.23e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAT—rheumatoid arthritis	4.96e-06	5.09e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SPP1—rheumatoid arthritis	4.88e-06	5.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—rheumatoid arthritis	4.78e-06	4.9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR5—rheumatoid arthritis	4.75e-06	4.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TYK2—rheumatoid arthritis	4.71e-06	4.83e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2RA—rheumatoid arthritis	4.68e-06	4.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—C3—rheumatoid arthritis	4.64e-06	4.76e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—rheumatoid arthritis	4.62e-06	4.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—rheumatoid arthritis	4.61e-06	4.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—rheumatoid arthritis	4.32e-06	4.43e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—rheumatoid arthritis	4.28e-06	4.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1B—rheumatoid arthritis	4.26e-06	4.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—rheumatoid arthritis	4.26e-06	4.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—rheumatoid arthritis	4.24e-06	4.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—rheumatoid arthritis	4.23e-06	4.34e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	4.14e-06	4.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FN1—rheumatoid arthritis	4.07e-06	4.18e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6ST—rheumatoid arthritis	4.06e-06	4.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCR5—rheumatoid arthritis	4.02e-06	4.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFKB1—rheumatoid arthritis	3.97e-06	4.08e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAT—rheumatoid arthritis	3.94e-06	4.04e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—rheumatoid arthritis	3.93e-06	4.03e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—rheumatoid arthritis	3.91e-06	4.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MAPK8—rheumatoid arthritis	3.91e-06	4.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD80—rheumatoid arthritis	3.91e-06	4.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—POMC—rheumatoid arthritis	3.71e-06	3.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—rheumatoid arthritis	3.63e-06	3.72e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6R—rheumatoid arthritis	3.62e-06	3.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6ST—rheumatoid arthritis	3.43e-06	3.52e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—rheumatoid arthritis	3.41e-06	3.49e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—POMC—rheumatoid arthritis	3.31e-06	3.4e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD80—rheumatoid arthritis	3.3e-06	3.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TYK2—rheumatoid arthritis	3.3e-06	3.38e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	3.29e-06	3.37e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—rheumatoid arthritis	3.24e-06	3.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6R—rheumatoid arthritis	3.06e-06	3.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—rheumatoid arthritis	3.06e-06	3.13e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—rheumatoid arthritis	3.02e-06	3.1e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—rheumatoid arthritis	2.89e-06	2.96e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—rheumatoid arthritis	2.87e-06	2.94e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TYK2—rheumatoid arthritis	2.79e-06	2.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—rheumatoid arthritis	2.74e-06	2.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—rheumatoid arthritis	2.74e-06	2.81e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	2.64e-06	2.71e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—POMC—rheumatoid arthritis	2.63e-06	2.7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—rheumatoid arthritis	2.6e-06	2.66e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKB1—rheumatoid arthritis	2.57e-06	2.64e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MAPK8—rheumatoid arthritis	2.53e-06	2.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—rheumatoid arthritis	2.52e-06	2.59e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—rheumatoid arthritis	2.49e-06	2.56e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—rheumatoid arthritis	2.4e-06	2.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—rheumatoid arthritis	2.33e-06	2.39e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—rheumatoid arthritis	2.3e-06	2.36e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—rheumatoid arthritis	2.29e-06	2.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—rheumatoid arthritis	2.14e-06	2.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—rheumatoid arthritis	1.81e-06	1.86e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—rheumatoid arthritis	1.76e-06	1.81e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—rheumatoid arthritis	1.61e-06	1.65e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—rheumatoid arthritis	1.36e-06	1.4e-05	CbGpPWpGaD
